Joint ECDC and EMCDDA rapid risk assessment: HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania
In response to a notified increase in HIV cases among injecting drug users (IDU) in Greece and Romania, the European Commission asked the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in November 2011 to conduct a rapid inquiry among their network of HIV surveillance- and drug focal points to investigate whether such increases had occurred in other countries. The assessment showed that while most European countries reported no changes in the rate of newly diagnosed cases of HIV or HIV prevalence in IDU in 2011, increases were documented in six countries. Indicators of injecting risk and prevention coverage show a potential risk for increased HIV transmission and future outbreaks in several countries.
See also the Joint Guidance Prevention and control of infectious diseases among people who inject drugs
On 17 January 2012, Table A1 was amended to include footnote 22.
Rapid Risk Assessment: Potential public health risks related to communicable diseases at the WorldPride festival in Madrid, 23 June–2 July 2017
8 May 2017 - This rapid risk assessment reviews the health risks related to communicable diseases in the context of the WorldPride festival in Madrid, from 23 June to 2 July 2017.
Risk assessment on change of testing requirements for partner donation of reproductive cells
12 Jun 2012 - In May 2011, the European Commission asked ECDC to estimate the change in total exposure risk to hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) during reproductive cell handling and storage for secondary parties, if the current scheme of testing at each cell donation would change to testing partner donors of reproductive cells once or twice a year.